International Journal of Endocrinology / 2013 / Article / Tab 1 / Research Article
Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes Table 1 Baseline characteristics of pregnant women receiving ILPS or NPH insulin.
ILPSg NPHg
No. 53 36 Type of diabetes (T2DM/GDM) 7/46 18/18 0.0002 Caucasian ethnicity (%) 90.6 (48/53) 91.7 (33/36) ns Age (yrs) Total 34.7
5.8 34.2
4.8 ns T2DM 36.0
4.3 33.4
5.3 ns GDM 34.5
6.0 34.9
4.3 ns Prepregnancy BMI (kg/m2 ) Total 28.6
5.7 28.8
7.2 ns T2DM 30.9
6.0 29.2
7.2 ns GDM 28.3
5.7 28.4
7.3 ns Gestational week at 1st visit Total 22.2
8.4 14.1
8.9 <0.0001 T2DM 15.4
9.6 9.2
6.6 ns GDM 23.3
7.8 19.0
8.3 ns Gestational week at enrollment Total 27.8
8.1 20.3
11.1 0.0004 T2DM 15.4
13.2 11.1
7.1 ns GDM 29.1
6.3 29.5
4.9 ns Weight increase at enrollment (kg) Total 7.7
6.7 4.4
4.4 0.01 T2DM 4.7
6.7 1.7
2.4 ns GDM 8.2
6.7 7.1
4.3 ns Preenrollment short-acting insulin dose (units/kg/day) Total 0.18
0.10 0.27
0.16 0.01 T2DM 0.22
0.13 0.30
0.18 ns GDM 0.18
0.09 0.23
0.14 ns
BMI: body mass index; T2DM: type 2 diabetes mellitus; GDM: gestational diabetes mellitus.
